- Home
- COEP vs GSIW Comparison
COEP vs GSIW Comparison
Compare COEP & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- GSIW
- Stock Information
- Founded
- COEP 2017
- GSIW 2016
- Country
- COEP United States
- GSIW Hong Kong
- Employees
- COEP N/A
- GSIW N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- GSIW
- Sector
- COEP Health Care
- GSIW
- Exchange
- COEP Nasdaq
- GSIW Nasdaq
- Market Cap
- COEP 27.4M
- GSIW 27.2M
- IPO Year
- COEP N/A
- GSIW 2023
- Fundamental
- Price
- COEP $11.26
- GSIW $1.75
- Analyst Decision
- COEP
- GSIW
- Analyst Count
- COEP 0
- GSIW 0
- Target Price
- COEP N/A
- GSIW N/A
- AVG Volume (30 Days)
- COEP 38.9K
- GSIW 2.6M
- Earning Date
- COEP 08-15-2025
- GSIW 01-01-0001
- Dividend Yield
- COEP N/A
- GSIW N/A
- EPS Growth
- COEP N/A
- GSIW N/A
- EPS
- COEP N/A
- GSIW N/A
- Revenue
- COEP $62,874.00
- GSIW $1,313,795.00
- Revenue This Year
- COEP N/A
- GSIW N/A
- Revenue Next Year
- COEP N/A
- GSIW N/A
- P/E Ratio
- COEP N/A
- GSIW N/A
- Revenue Growth
- COEP N/A
- GSIW N/A
- 52 Week Low
- COEP $2.31
- GSIW $0.35
- 52 Week High
- COEP $13.70
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- COEP 74.07
- GSIW 72.13
- Support Level
- COEP $7.25
- GSIW $1.26
- Resistance Level
- COEP $10.00
- GSIW $1.66
- Average True Range (ATR)
- COEP 0.66
- GSIW 0.14
- MACD
- COEP 0.36
- GSIW -0.02
- Stochastic Oscillator
- COEP 90.20
- GSIW 92.25
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.